Correlation study of FGF23/D-serine in maintenance hemodialysis patients with combined hearing impairment
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0280378 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Dunlu Yuan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Affiliated Hospital of Kunming Medical University, Kunming, China. Hauptthemen laut MEDLINE: Kidney Failure, Chronic, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Major Teaching Educational Reform Project of Kunming Medical University, the Project of College Education Cooperation Project of Yunnan Province, the Subproject of Fund of CKD Clinical Research Center in Yunnan Province.
Abstract (Originalsprache)
Background
Recent studies have reported an association between chronic renal failure and hearing impairment. Yet, the exact mechanism of action is still not fully understood. In this study, we investigated the expression of fibroblast growth factor 23 (FGF23) and D-serine in maintenance hemodialysis (MHD) patients with end-stage renal disease (ESRD) complicated with hearing impairment and further investigated the correlation between FGF23/D-serine and hearing impairment.
Methods
A total of 90 subjects, including 30 MHD patients complicated with hearing impairment, 30 MHD patients with normal hearing, and 30 controls, were included in this case-control study. Relevant data were obtained by questionnaire survey, audiometric test, enzyme-linked immunosorbent assay (ELISA) to determine FGF23 level, and high-performance liquid chromatography to determine D-serine level.
Results
MHD patients showed abnormally high expression of FGF23 and D-serine, where FGF23 and D-serine levels were significantly higher in the group with hearing impairment than in the group with normal hearing and normal controls (all P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
- Department of Otolaryngology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
- Department of Medical Record, The Third People's Hospital of Kunming, Kunming, China.
ORCID-Profile: Qing Li
Förderung
- the Major Teaching Educational Reform Project of Kunming Medical University
- the Project of College Education Cooperation Project of Yunnan Province
- the Subproject of Fund of CKD Clinical Research Center in Yunnan Province
- the Project of Yunnan health training project of high level talents
- Hundred of young and middle-aged academic and technical talent in Kunming Medical University
Zitieren
APA
Yuan, D., Li, J., Guo, M., Yang, Q., Huang, J., Nie, J., Li, R., & Li, Q. (2023). Correlation study of FGF23/D-serine in maintenance hemodialysis patients with combined hearing impairment. PLOS ONE. https://doi.org/10.1371/journal.pone.0280378
Vancouver
Yuan D, Li J, Guo M, Yang Q, Huang J, Nie J, et al. Correlation study of FGF23/D-serine in maintenance hemodialysis patients with combined hearing impairment. PLOS ONE. 2023. doi:10.1371/journal.pone.0280378
BibTeX
@article{Yuan2023,
author = {Yuan, Dunlu and Li, Jiaqing and Guo, Min and Yang, Qing and Huang, Jingjing and Nie, Jingwen and Li, Ruomei and Li, Qing},
title = {Correlation study of FGF23/D-serine in maintenance hemodialysis patients with combined hearing impairment},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0280378}
}
EUVIMED